Cdh-1/Hct1 Monoclonal Antibody : Trial Size
Code No: K0085-3S
Datasheet:
FID:5338 | PATH:sites/default/files/datasheets/K0085-3S.PDF
Background:
Two highly conserved WD40-repeat proteins, Cdc20 and Cdh1/Hct1, have been identified as limiting, substrate-specific regulators for anaphase-promoting complex (APC)-dependent proteolysis. Cdc20 and Cdh1 bind directly to APC and activate its cyclin ubiquitination activity. Cdc20 activates APC at the onset of anaphase, while Cdh1 activates APC from late anaphase through G1. Phosphorylation of Cdh1 by cyclin dependent kinases (Cdks), such as Cdc28, blocked Cdh1-APC interaction and APC activation, while dephosphorylation by the phosphatase Cdc14 restored this activity. Activation of the APC and cyclin degradation is required for exit from mitosis; hence, the phosphorylation of Cdc20 and Cdh1 by Cdks regulate APC activity and may control the precise progression of mitosis.
Product Type:
Primary Antibody
Species Reactivities:
Human
Species Reactivities:
Mouse
Species Reactivities:
Rat
Related Products:
MD-17-3 Anti-Cyclin D1 (5D4)
K0062-3S Anti-Cyclin D1 (DCS-6)
K0063-3 Anti-Cyclin D2 (DCS-3)
K0064-3S Anti-Cyclin D2 (DCS-5)
K0013-3S Anti-Cyclin D3 (DCS-22)
MT-19-3S Anti-Cdc2Hs (5F6)
K0069-3S Anti-CDC6 (DCS-180)
K0070-3S Anti-CDC7 (DCS-342)
K0071-3S Anti-CDC25A (DCS-120)
K0072-3S Anti-CDC25A (DCS-121)
K0073-3S Anti-CDC25A (DCS-124)
MK-13-3S Anti-Cdk2 (8A12)
K0065-3S Anti-Cdk4 (DCS-156)
K0066-3S Anti-Cdk6 (DCS-83)
K0067-3 Anti-Cdk6 (DCS-130) available soon
K0068-3S Anti-Cdk7 (DCS-MO1)
K0077-3S Anti-p16INK4a (DCS-50)
K0078-3 Anti-p15INK4b (DCS-114) available soon
K0079-3S Anti-p18INK4c (DCS-118)
K0080-3S Anti-p19INK4d (DCS-100)
K0081-3S Anti-p21WAF1/CIPP1 (DCS-60)
K0082-3S Anti-p27KIPP1 (DCS-72)
K0084-3S Anti-p14ARF (DCS-240)
K0087-3S Anti-Chk2 (DCS-270)
K0088-3S Anti-Chk2 (DCS-273)
K0094-3S Anti-E2F-4 (TFE42)
K0095-3S Anti-DP-1 (TFD10)
M069-3S Anti-Mcm2 (4B8)
M038-3S Anti-Mcm3 (3A2)
M049-3S Anti-Mcm7 (4B4)
MK-15-1S Anti-RB (3H9)
M045-3S Anti-phospho RB (2C4)
K0091-3S Anti-RB2 (DCS-211)
K0089-3 Anti-Plk1 (DCS-PL6) available soon
K0090-3 Anti-Securin (DCS-280) available soon
References:
1) Sorensen, C.S., et al. Mol. Cell. Biol. 21, 3692-3703 (2001)
Formulation:
10 g IgG in 50 L volume of PBS containing 1% BSA, 10% glycerol and 0.1% sodium azide as preservative. Sodium azide has been reported to form potentially explosive lead or copper azide in plumbing. To prevent forming of these compounds, flush drains enough after disposing of solutions containing sodium azide.
Reactivity:
This antibody reacts with human, mouse and rat Cdh1.
Intended Use:
For Research use only. Not for use in diagnostic procedure.
|